Transepicardial with Transseptal CD 133+ Implantation
LB.02.01/VII/086/KEP.007.EV
Approved mab completed
Quick answer
Transepicardial with Transseptal CD 133+ Implantation for Coronary Artery Disease is a Approved program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Coronary Artery Disease
- Phase
- Approved
- Modality
- mab
- Status
- completed